Covalent binding and inhibition of cytochrome P4502E1 by trichloroethylene

Xenobiotica

Volumn 27, Issue 1, 1997, Pages 101-110

  Halmes, N C ^a   Samokyszyn, V M ^a   Pumford, N R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DOSE RESPONSE; DRUG PROTEIN BINDING; ENZYME ACTIVITY; IMMUNOBLOTTING; LIVER MICROSOME; MALE; METABOLIC ACTIVATION; MOUSE; NONHUMAN;

ANIMALS; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; DENSITOMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICROSOMES, LIVER; PROTEIN BINDING; TRICHLOROETHYLENE;

ANIMALIA;

EID: 0031035604     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982597240794     Document Type: Article

References (29)

1. ALLEMAND, H., PESSAYRE, D., DESCATOIRE, V., DEGOTT, C., FELDMANN, G. and BENHAMOU, J. P., 1978, Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver. Journal of Pharmacology and Experimental Therapeutics, 204, 714-723.
2. BOURDI, M., CHEN, W., PETER, R. M., MARTIN, J. L., BUTERS, J. T. M., NELSON, S. D. and POHL, L. R., 1996, Human P4502E1 is a major autoantigen associated with halothane hepatitis. Chemical Research in Toxicology, 9, 1159-1166.
3. BRUCKNER, J. V., DAVIS, B. D. and BLANCATO, J. N., 1989, Metabolism, toxicity, and carcinogenicity of trichloroethylene. Critical Reviews in Toxicology, 20, 31-50.
4. BUBEN, J. A. and O'FLAHERTY, K. J., 1985, Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicology and Applied Pharmacology, 78, 105-122.
5. DAVIDSON, I. W. and BELILES, R. P., 1991, Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metabolism Reviews, 23, 493-599.
6. ELIASSON, E. and KENNA, J. G., 1996, Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Molecular Pharmacology, 50, 573-582.
7. GOEPTAR, A. R., COMMANDEUR, J. N. M., VAN OMMEN, B., VAN BLADEREN, P. J. and VERMEULEN, N. P. E., 1995, Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chemical Research in Toxicology, 8, 3-21.
8. GREEN, T., 1990, Chloroethylenes: a mechanistic approach to human risk evaluation. Annual Reviews in Pharmacology, 30, 73-89.
9. HALMES, N. C., MCMILLAN, D. C., OATIS, J. J. E. and PUMFORD, N. R., 1996a, Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chemical Research in Toxicology, 9, 451-456.
10. HALMES, N. C., HINSON, J. A., MARTIN, B. A. and PUMFORD, N. R., 1996b, Glutamate dehydrogenase covalently binds to a reactive metabolite of acetaminophen. Chemical Research in Toxicology, 9, 541-546.
11. HENSCHLER, D., VAMVAKAS, S., LAMMERT, M., DEKANT, W., KRAUS, B., THOMAS, B. and ULM, K., 1995, Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene. Archives of Toxicology, 69, 291-299.
12. IARC, 1995, Dry cleaning, some chlorinated solvents and other industrial chemicals. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (Lyon : World Health Organization, International Agency for Research on Cancer), pp. 75-158.
13. KHAN, M. F., KAPHALIA, B. S., PRABHAKAR, B. S., KANZ, M. F. and ANSARI, G. A., 1995, Trichloroethane-induced autoimmune response in female MRL +/+ mice. Toxicology and Applied Pharmacology, 134, 155-160.
14. KILBURN, K. H. and WARSHAW, R. H., 1992, Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environmental Research, 57, 1-9.
15. KOOP, D. R., 1986, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Molecular Pharmacology, 29, 399-404.
16. LECOEUR, S., BONIERBALE, E., CHALLINE, D., GAUTIER, J. C., VALADON, P., DANSETTE, P. M., CATINOT, R., BALLET, F., MANSUY, D. and BEAUNE, P. H., 1994, Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chemical Research in Toxicology, 7, 434-442.
17. LOCKEY, J. E., KELLY, C. R., CANNON, G. W., COLBY, T. V., ALDRICH, V. and LIVINGSTON, G. K., 1987, Progressive systemic sclerosis associated with exposure to trichloroethylene. Journal of Occupational Medicine, 29, 493-496.
18. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
19. MILLER, R. E. and GUENGERICH, F. P., 1983, Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450. Cancer Research, 43, 1145-1152.
20. ORTIZ DE MONTELLANO, P. R., 1995, Oxygen activation and reactivity. In Cytochrome P450 : Structure, Mechanism, and Biochemistry, edited by P. R. Ortiz de Montellano (New York: Plenum), pp. 245-303.
21. ORTIZ DE MONTELLANO, P. R. and CORREIA, M. A., 1983, Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annual Review of Pharmacology and Toxicology, 23, 481-503.
22. ORTIZ DE MONTELLANO, P. R. and CORREIA, M. A., 1995, Inhibition of cytochrome P450 enzymes. In Cytochrome P450 : Structure, Mechanism, and Biochemistry, edited by P. R. Ortiz de Montellano (New York: Plenum), pp. 305-364.
23. OSAWA, Y. and POHL, L. R., 1989, Covalent binding of the prosthetic heme to protein: a potential mechanism for the suicide inactivation or activation of hemoproteins. Chemical Research in Toxicology, 2, 131-141.
24. PHOON, W. H., CHAN, M. O., RAJAN, V. S., TAN, K. J., THIRUMOORTHY, T. and GOH, C. L., 1984, Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene. Contact Dermatitis, 10, 270-276.
25. cam. In Cytochrome P450 : Structure, Mechanism, and Biochemistry, edited by P. R. Ortiz de Montellano (New York: Plenum), pp. 505-523.
26. TIERNEY, D. J., HAAS, A. L. and KOOP, D. R., 1992, Degradation of cytochrome P450 2E1 : selective loss after labilization of the enzyme. Archives of Biochemistry and Biophysics, 293, 9-16.
27. WALLER, P. A., CLAUW, D., CUPPS, T., METCALF, J. S., SILVER, R. M. and LEROY, E. C., 1994, Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). Journal of Rheumatology, 21, 1567-1570.
28. WEISS, N. S., 1996, Cancer in relation to occupational exposure to trichloroethylene. Occupational and Environmental Medicine, 53, 1-5.
29. YANEZ DIAZ, S., MORAN, M., UNAMUNO, P. and ARMIJO, M., 1992, Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology, 184, 98-102.